Innocan Pharma collaborates with Tel Aviv University to develop a new revolutionary approach to treat the COVID-19 coronavirus with exosomes-loaded CBD

April 20, 2020 Leave a comment 2,069 Views

InnoCan Pharma announced that its wholly-owned subsidiary, InnoCan Pharma Ltd. of Herzliya Israel, has entered into a sponsored research agreement with Ramot at Tel Aviv University to collaborate with Tel Aviv university to develop a novel, revolutionary...

Exosome RNA Exosome RNA Research & Industry News

Tag Archives: Ramot

Innocan Pharma collaborates with Tel Aviv University to develop a new revolutionary approach to treat the COVID-19 coronavirus with exosomes-loaded CBD

EV study reveals protein kinases significantly contribute to the immunodeficiency in HIV patients

Exosomes – powerful weapon for cancer nano-immunoengineering

Find One-stop Exosome Services at Creative Biolabs for Various Applications

Innate immunity communicates using the language of extracellular microvesicles

WO2021033990 – Composition Comprising Exosomes Derived from Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cell Precursor for Prevention or Treatment of Non-Alcoholic Steatohepatitis

Researchers use new tool to study how stress impacts outer membrane vesicle composition in root-colonizing bacteria